Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
Guangzhou Boji Medical Biotechnological co.,Ltd
Guangzhou Boji Medical Biotechnological co.,Ltd (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd
Guangzhou Boji Medical Biotechnological co.,Ltd (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
service content
Video
  • Company News
  • Industry News
  • Regulations and Policies
  • Good news! Boji won the top 20 Chinese CRO (including CDMO) companies in 2019!
    2020/09/16
    On August 25, 2020 National Pharmacy Week and China's Top 100 Pharmaceutical Industry Annual Meeting was held in Kunming. At the meeting, Minai.com, a data information service platform in the medical and health field, released the 2019 China Pharmaceutical Industry Top 100 Series list. Boji Pharmaceuticals was on the list and was selected into the 2019 China CRO (including CDMO) TOP20 list.
Boji pharmaceutical
  • Founding Time
    Founded in 2002
  • Industry
    Contract Research Organization
  • Market Status
    Leading domestic CRO enterprises; International and well-known companies
  • Number Of Employees
    More than 700 pharmaceutical researchers
  • Development History

    After 18 years of development, Boji Pharmaceutical has ranked among China's CRO companies in terms of technical strength, service quality, service scope, operating income, team building.


  • Company Culture

    Strategic goals: Consolidate domestic leadership, achieve international leadership and build acentury-old brand.

    Business philosophy: Think for customers, serve customers, make progress together with customers.


Cooperation Agency

Our company always adheres to the concept of "professional, honest, enterprising and harmonious". After nearly a decade of clinical research in new drugs, our company has achieved rapid development.


  • Phone:400-0020-628
  • Address:7th Floor, Building A, Vanke Cloud Plaza, 1933 Huaguan Road, Tianhe District, Guangzhou
Copyright © 广州博济医药生物技术股份有限公司 All Rights Reserved 粤ICP备13039920号 (粤)—非经营性—2020-0084 Powered by vancheer
Copyright © 广州博济医药生物技术股份有限公司 All Rights Reserved 粤ICP备13039920号 (粤)—非经营性—2020-0084 Powered by vancheer